ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer.

Lee S Rosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.